Interstitial lung disease in patients treated with antibody-drug conjugates: a review
{{output}}
Background: Antibody-drug conjugates (ADCs) are increasingly used across solid tumors, including lung cancer, but drug-related interstitial lung disease (ILD)/pneumonitis has emerged as a clinically relevant and potentially fatal... ...
